Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Boisclair
Brian Boisclair, Goffstown, NH US
| Patent application number | Description | Published |
|---|---|---|
| 20100012351 | SPACERS FOR CABLE CONDUCTORS - Spacers for use on power distribution lines are disclosed that include a body, a messenger hook, and a conductor hook. A messenger clamp is pivotally connected to the messenger hook, and is rotatable from an open position to a messenger engaging position. A conductor clamp is pivotally connected to the conductor hook, and is rotatable from an open position to a conductor engaging position. | 01-21-2010 |
| 20100018014 | MESSENGER CLAMP - Messenger clamps can be formed from two messenger clamp halves. Messenger clamps and messenger clamp halves can include break away portions, which allow a messenger wire to fall when subjected to high impact forces such as a tree falling on the messenger wire. A messenger clamp half for use in forming a messenger clamp can include an inside face having a first clamping groove and a second clamping groove, and an outside face having at least one fault groove. A break away portion of the messenger clamp half can include one of the clamping grooves, and can further includes at least a portion of the fault groove. | 01-28-2010 |
| 20120102683 | MESSENGER CLAMP - Messenger clamps can be formed from two messenger clamp halves. Messenger clamps and messenger clamp halves can include break away portions, which allow a messenger wire to fall when subjected to high impact forces such as a tree falling on the messenger wire. A messenger clamp half for use in forming a messenger clamp can include an inside face having a first clamping groove and a second clamping groove, and an outside face having at least one fault groove. A break away portion of the messenger clamp half can include one of the clamping grooves, and can further includes at least a portion of the fault groove. | 05-03-2012 |
Gaetan Boisclair, Longueuil CA
| Patent application number | Description | Published |
|---|---|---|
| 20100099335 | CHANNEL INLET EDGE DEBURRING FOR GAS DIFFUSER CASES - A method of deburring channel inlet edges inside a cavity of a gas diffuser case is disclosed. The diffuser case has a plurality of channels each having an inner surface and an inlet edge defining an inlet of the channel. The surfaces of adjacent channels co-operate to provide said inlet edge therebetween. The inlet edges of the channels are provided in an inwardly facing circular array around a central axis of the gas diffuser case. The method comprises: inserting a tool head having at least one nozzle in the cavity of the gas diffuser case; and then ejecting abrasive particles from at least one nozzle towards at least one of the channel inlet edges of the gas diffuser case to at least one of decrease a radius of at least one said edge and improve a smoothness of at least one said surface. | 04-22-2010 |
Julie Boisclair, Birsfelden CH
| Patent application number | Description | Published |
|---|---|---|
| 20100221186 | BIOMARKERS FOR CARDIOVASCULAR SIDE-EFFECTS INDUCED BY COX-2 INHIBITORY COMPOUNDS - Cardiovascular tissue mRNA expression profiles in monkeys treated with coxibs was analyzed. Genomic data indicated that the animals showing vasculitis exhibit a specific mRNA expression pattern. The pattern includes gene expression changes involved in blood and endothelial cell (EC) activation, interaction of blood cells with EC, activation of INFγ pathway, and release of pro-inflammatory cytokines and chemo-attractants. These results provide direct evidence of minimal vasculitis together with corresponding genomic signature and peripheral biomarkers for minimal vasculatis. These results also suggest that treatment might triggers/aggravate a clinically latent cardiovascular disorder in the context of an endothelium tropic viral infection and/or an autoimmune vascular disorder. The histopathological examination revealed marginal vascular changes consistent with the genomic findings. Measurement of soluble proteins present in serum and plasma using a multiplex assay were in line with the genomic results, showing the increased level of INFγ inducible proteins, increased expression of CXCL10 chemokine was confirmed by an ELISA both in serum and plasma. Use of these peripheral biomarkers allows a safe usage of cox-2 inhibitory compounds in clinics and selection of cox-2 inhibitory follow-up compounds with no cardiovascular toxicity. These data together with biochemical and histopathological findings suggest that the specific cox2 inhibitor may exaggerate host immune response during some specific viral infections with endothelial tropism, or subjacent vascular autoimmune disorders. | 09-02-2010 |
Mathieu Boisclair, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20120136400 | METHOD FOR CO-PROCESSING COMPONENTS IN A METAL INJECTION MOLDING PROCESS, AND COMPONENTS MADE VIA THE SAME - A method comprising molding a first component from a first feedstock comprising a first material powder and a first binder, molding a second component from a second feedstock comprising a second material powder and a second binder, placing the first component and the second component in physical communication with each other in order to form an assembled component, removing the first binder and the second binder from the assembled component and performing a sintering operation on the assembled component so as to bond the first component and the second component together. | 05-31-2012 |